Physical Therapists in Perryville, MD Accepting Medicare

7 Physical Therapists found. Showing 1 - 7

Joshua Harmon, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 5301 Pulaski Hwy Ste L, Perryville, MD 21903 Phone: 443-243-9922

Align Physical Therapy Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 5301 Pulaski Hwy Ste L, Perryville, MD 21903 Phone: 443-471-6086

Alec Levesque Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4853 Pulaski Hwy Ste 315, Perryville, MD 21903 Phone: 443-693-8000    Fax: 410-642-2581

Lee Ann Nelson Physical Therapy Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4899 Pulaski Highway, Suite A, Perryville, MD 21903 Phone: 410-392-9400    Fax: 410-392-0577

Brandon Scott Ho, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4853 Pulaski Hwy Ste 315, Perryville, MD 21903 Phone: 443-693-8000    Fax: 410-642-2581

Ati Physical Therapy Perryville Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4853 Pulaski Hwy Ste 315, Perryville, MD 21903 Phone: 443-693-8000    Fax: 410-642-2581

Ati Holding Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4853 Pulaski Hwy Ste 315, Perryville, MD 21903 Phone: 443-693-8000

News Archive

Advaxis submits protocol revision for ADXS-HPV CIN Phase II study

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has submitted a protocol revision that has passed FDA review for the enrollment of the next 40 subject "mid strength" dose cohort in the dose-ranging Phase II study of ADXS-HPV, an immunotherapy for Cervical Intraepithelial Neoplasia.

Higher ozone levels linked to greater heart risk associated with high temperatures

Ozone may prove the key to the link between high temperature and the increased risk of death from heart disease or stroke, suggests research published ahead of print in Occupational and Environmental Medicine .

Age-related macular degeneration associated with increased mortality risk

Individuals age 49 and older with cataract and those age 49 to 74 years with age-related macular degeneration appear to have higher mortality rates over an 11-year period than those without such visual impairments, according to a report in the July issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

Cempra commences Phase 2/3 clinical study of CEM-102 for treating acute bacterial skin structure infections

Cempra Pharmaceuticals today announced that enrollment is underway in an adaptive design Phase 2/3 clinical study with CEM-102 for patients suffering from acute bacterial skin structure infections (ABSSI). CEM-102 is an oral antibiotic with an established record of treating staphylococcal infections outside the United States, including those due to methicillin-resistant Staphylococcus aureus (MRSA).

Read more Medical News

› Verified 4 days ago